FLECAINIDE ACETATE Drug Patent Profile
✉ Email this page to a colleague
When do Flecainide Acetate patents expire, and what generic alternatives are available?
Flecainide Acetate is a drug marketed by Amneal Pharm, Ani Pharms, Aurobindo Pharma Ltd, Beximco Pharms Usa, Chartwell, Hikma, Sun Pharm Inds Ltd, and Yichang Humanwell. and is included in nine NDAs.
The generic ingredient in FLECAINIDE ACETATE is flecainide acetate. There are ten drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the flecainide acetate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Flecainide Acetate
A generic version of FLECAINIDE ACETATE was approved as flecainide acetate by AMNEAL PHARM on July 31st, 2001.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for FLECAINIDE ACETATE?
- What are the global sales for FLECAINIDE ACETATE?
- What is Average Wholesale Price for FLECAINIDE ACETATE?
Summary for FLECAINIDE ACETATE
| US Patents: | 0 |
| Applicants: | 8 |
| NDAs: | 9 |
| Finished Product Suppliers / Packagers: | 15 |
| Raw Ingredient (Bulk) Api Vendors: | 79 |
| Clinical Trials: | 5 |
| Patent Applications: | 740 |
| Drug Prices: | Drug price information for FLECAINIDE ACETATE |
| DailyMed Link: | FLECAINIDE ACETATE at DailyMed |
Recent Clinical Trials for FLECAINIDE ACETATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| InCarda Therapeutics, Inc. | Phase 3 |
| InCarda Therapeutics, Inc. | Phase 2 |
| InCarda Therapeutics Australia Pty Ltd. | Phase 2 |
Pharmacology for FLECAINIDE ACETATE
| Drug Class | Antiarrhythmic |
Medical Subject Heading (MeSH) Categories for FLECAINIDE ACETATE
Anatomical Therapeutic Chemical (ATC) Classes for FLECAINIDE ACETATE
US Patents and Regulatory Information for FLECAINIDE ACETATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amneal Pharm | FLECAINIDE ACETATE | flecainide acetate | TABLET;ORAL | 075442-001 | Jul 31, 2001 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Chartwell | FLECAINIDE ACETATE | flecainide acetate | TABLET;ORAL | 079164-003 | Jul 9, 2009 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Sun Pharm Inds Ltd | FLECAINIDE ACETATE | flecainide acetate | TABLET;ORAL | 076421-003 | Mar 28, 2003 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Ani Pharms | FLECAINIDE ACETATE | flecainide acetate | TABLET;ORAL | 076030-002 | Oct 28, 2002 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
